Glucose-Na-K Baxter

Glucose-Na-K Baxter is an intravenous solution containing magnesium chloride hexahydrate, potassium chloride, sodium chloride, glucose, and sodium acetate trihydrate. Formulated for fluid and electrolyte replacement, it delivers water, electrolytes and glucose directly into the bloodstream. The product is supplied in a sterile liquid form and is marketed in the European Union for use under prescription by healthcare professionals.

Glucose-Na-K Baxter is indicated for clinical situations that require rapid volume expansion and electrolyte repletion. It is commonly employed in the following contexts:

- Treatment of dehydration caused by gastrointestinal losses or inadequate oral intake. - Support during surgery or invasive procedures to maintain intravascular volume. - Management of electrolyte imbalances such as hypokalemia, hyponatremia, or hypomagnesemia. - Provision of metabolic substrate (glucose) in patients unable to receive enteral nutrition. - Adjunct therapy in critical care settings for patients with shock or sepsis.

Adverse reactions to Glucose-Na-K Baxter are generally related to its electrolyte composition and infusion characteristics.

Common: - Mild infusion site irritation or phlebitis. - Transient hyperglycemia. - Slight electrolyte shifts (e.g., mild hyperkalemia). - Nausea or vomiting. - Headache. - Flushing or warmth at the infusion site.

Serious: - Severe hyperkalemia leading to cardiac arrhythmia. - Hypermagnesemia causing respiratory depression. - Anaphylactic or severe allergic reaction. - Volume overload with pulmonary edema. - Metabolic acidosis from acetate accumulation. - Hemolysis due to rapid infusion rates.

When administering Glucose-Na-K Baxter, clinicians should observe several safety considerations. Proper patient assessment and monitoring are essential to minimize risks.

- Verify electrolyte levels and renal function before initiation. - Adjust infusion rate to avoid rapid volume expansion. - Monitor cardiac rhythm in patients at risk for hyperkalemia. - Use caution in patients with heart failure or fluid overload. - Assess for signs of allergic reaction during the first infusion. - Ensure compatibility with other IV solutions and medications. - Document infusion parameters and patient response accurately.

Glucose-Na-K Baxter may interact with other medications that affect electrolyte balance or fluid status. Awareness of these interactions helps prevent complications.

Avoid: - Concurrent administration of high-dose potassium supplements without monitoring. - Use of other magnesium-containing IV solutions that could cause hypermagnesemia. - Co‑infusion with acidic drugs that may precipitate salts.

Use with caution: - Loop diuretics, which can alter potassium and magnesium levels. - ACE inhibitors or ARBs, which may increase serum potassium. - Insulin therapy, which can shift glucose and potassium intracellularly. - Blood transfusions, which may affect calcium and magnesium balance.